Abstract BACKGROUND Stereotactic Radiosurgery (SRS) for patients with intracranial disease is increasing, especially for smaller and more numerous metastases. In England, Varian HyperArc using a Truebeam linac is nationally commissioned via benchmarking. HyperArc contains SRS-specific optimisation and non-coplanar VMAT delivery and is an attractive option due to its cost effectiveness compared with competing specialised platforms such as Elekta GammaKnife and Accuray CyberKnife. Depsite these benefits, the treatment of small targets or those with highly complex shapes is dominated by specialised platforms with a largely stated reason being perceived concern over delivered dosimetric certainty. This work assesses achievable dosimetric accuracy for complex SRS using Varian HyperArc suing a standard 120-leaf 5mm width MLC. MATERIAL AND METHODS Four patients with small and/or complex PTVs previously treated with CyberKnife at our institution were identified:26 metastases 24Gy/1f (PTV min. volume 0.01cc);5 metastases 24 Gy/1f (PTV min. volume 0.11cc);Pituitary adenoma 25Gy/1f (PTV width min. 5 mm near optics);Acoustic neuroma 21 Gy/3f (PTV width min. 3 mm near cochlea). Patients were re-planned with HyperArc using 4 arcs at 6FFF, emulating the prescription dose spillage (PDS) & modified gradient index (mGI) achieved in the CyberKnife plans. Plans were produced in Eclipse v17.1, calculated using the AAA algorithm (v 17.1.0.1) on a 1mm calculation grid. The plan was then transferred to a CT scan of an in-house water equivalent phantom containing radiochromic EBT3 film in clinically meaningful coronal and sagittal dose planes and re-calculated. All plans were delivered under image guidance and the 2D film dosimetry was compared with the calculated dose from Eclipse using a global 5%/1mm (TH 20%) gamma test using well-established absolute dose film methodology in Sun Nuclear SNC Patient (v 8.2). RESULTS In all cases, HyperArc had very similar plan quality to CyberKnife, with maximum dose gradients between 20-23% of prescription dose per mm beyond the PTV (up to 5.8Gy/mm). Up to 1mm geometric offset was permitted to allow for imaging localization & film registration uncertainty in the analysis. Mean gamma pass rates were 93.3% pre-alignment and 98.5% post-alignment. CONCLUSION The very high gamma pass rates achieved in this novel work illustrate excellent delivered dose accuracy for high-quality SRS plans. The use of a radiochromic film dosimetry allows for the demonstration of such accuracy using a standard Truebeam linac without the use of a high-definition MLC even for the smallest and most complex SRS targets. This work enables us to re-think previously held beliefs around perceived dosimetric limitations of multi-arc VMAT with a 5 mm MLC width for the delivery of high-quality SRS. Removing this barrier could start to bridge the existing gap in worldwide SRS service provision for patients.
Read full abstract